Cultured tumor cells are highly dynamic in the expression of stem cell markers and CD133 positive cells, widely regarded as glioma stem cells, can develop from initially CD133 negative cells after prolonged culturing [58]. The gene discussed is PROM1; the disease is central nervous system cancer.